BBBoris V. Boldin

Boris V. Boldin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Boris V. Boldin has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Specific issues of using modern anticoagulants for prescribing thromboembolic complications during surgical interventions

    by A. V. Bocharov, A. A. Gruzdeva, D. K. Kopnenkova, K. A. Savostyanov, B. V. Boldin, K. V. Komov, N. O. Somov, G. A. Varich, А. В. Бочаров, А. А. Груздева, et al.

    Thromboembolic complications are among the most dangerous and, unfortunately, the most common lethal complications of elective surgical interventions. Today, anticoagulant therapy plays a leading role in preventing their occurrence in everyday clinical practice. A significant increase in the number of comorbid patients with the need for anticoagulant therapy for the prevention or treatment of venous thromboembolic complications requires surgeons to be aware of the specific issues of prescribing and/or discontinuing modern anticoagulant drugs. Today, low-molecular-weight heparins are the drugs of choice for routine prevention and long-term treatment of thrombotic complications. Traditionally, medical professionals consider these drugs similar and interchangeable, but they differ significantly in terms of their relative antithrombin activity, indications and contraindications in specific clinical situations, and the principles of dose adjustment. Currently, most patients requiring elective surgical interventions require a personalized approach to anticoagulant therapy.

  • Efficacy and safety of carotid endarterectomy, carotid stenting and optimal drug therapy for stenotic lesion combined with tortuosity of internal carotid artery: a systematic review and network meta-analysis

    by A.V. Bocharov, K.A. Savostyanov, B.V. Boldin, A.V. Gavrilenko, K.V. Komov

    The main factors of ischemic stroke are pathological changes in internal carotid arteries, such as stenosis due to atherosclerotic process and/or tortuosity. The purpose of this review was to compare efficacy and safety of «protected» internal carotid artery stenting, carotid endarterectomy with reconstructive component and optimal drug therapy for combination of internal carotid artery stenosis and tortuosity in adults. This systematic review and meta-analysis are based on the PRISMA recommendations. Endovascular methods did not show comparable efficacy and safety with open surgery, but also allowed inferiority of carotid artery stenting techniques as evidenced by wide confidence interval. Patients after surgical treatment have a lower risk of acute cerebrovascular accident compared to conservative treatment. High quality meta-analysis requires randomized or large cohort clinical trials comparing results of surgery, endovascular treatment and optimal drug therapy for combination of stenosis and tortuosity of internal carotid arteries.

  • Invasive interventions for asymptomatic stenotic internal carotid artery lesions in paradigm of modern optimal drug therapy

    by A.V. Bocharov, K.A. Savostyanov, B.V. Boldin, S.O. Bukaev

    Internal carotid artery ostium is the most common localization of stenotic lesions of extracranial arteries. Stroke in carotid basin usually follows acute occlusion of internal carotid artery as a result of atherosclerotic plaque rupture and vascular thrombosis, ineffective anticoagulation in patients with cardiac arrhythmias. The main purpose of invasive interventions for internal carotid artery stenosis is prevention of postoperative stroke. Currently, two surgical interventions are common: carotid endarterectomy (CEA) and “protected” internal carotid artery stenting (CAS). According to recommendations for the treatment of asymptomatic internal carotid artery stenosis, CEA combined with optimal drug therapy is preferable. However, several large meta-analyses demonstrated comparable long-term mortality and stroke rate for CEA and CAS. The purpose of this report was to highlight the results of large-scale studies comparing efficacy and safety of various surgical treatments with optimal drug therapy in patients with asymptomatic internal carotid artery stenosis receiving modern optimal drug therapy. When choosing any treatment strategy for asymptomatic carotid stenosis, one should pay attention to correction of modifiable risk factors for adverse cardiovascular events, including through optimal drug therapy. Additional studies are needed to stratify specific risk factors of stroke in patients with internal carotid artery stenosis in addition to asymptomatic status.

  • Open Access

    External abdominal wall hernias in rare locations

    by B. V. Boldin, N. O. Somov, V. Yu. Bogachev, G. A. Varich, V. A. Mirzonov

    Rarely localized external abdominal wall hernias represent a poorly studied yet clinically significant group of conditions characterized by atypical anatomical locations, a wide variety of anatomical variants, and a high rate of diagnostic errors. These hernias often present with subtle or nonspecific clinical manifestations and are frequently diagnosed at the stage of complications, which is associated with an increased risk of incarceration, postoperative complications, and mortality. The review article analyzed 45 full-text articles from electronic library databases and systematized modern information on rare external hernias of the abdominal cavity, including hernias of the Spigelian line, obturator foramen, sciatic, perineal hernias, hernias of the xiphoid process of the sternum and lumbar hernias. The clinical features, anatomical and morphological prerequisites for the formation of hernia defects, as well as the main diagnostic challenges are analyzed. The role of staging is noted, which is important for determining diagnostic tactics and choosing the optimal treatment method, especially considering the patient's age and, as a consequence, the risk of complications. Particular attention is paid to the role of imaging modalities, primarily computed tomography, as well as diagnosticlaparoscopy, in the timely detection of these types of hernias. It has been shown that rare hernias of the anterior abdominal wall represent a diagnostically and tactically complex group of pathologies, often detected only at the stage of complications. It is shown that the choice of surgical strategy should be individualized and determined by thelocation of the hernia defect, the presence of complications, and the patient’s comorbid status. Analysis of the availableliterature highlights the need for the standardization of diagnostic approaches and further accumulation of clinical experience in order to improve surgical outcomes in patients with rare external abdominal wall hernias.

  • RISK FACTORS FOR THE DEVELOPMENT OF COMPLICATIONS OF VARICOSE VEINS OF THE LOWER EXTREMITIES IN PREGNANT WOMEN

    by D.K. Kopnеnkova, A.V. Bocharov, B.V. Boldin, V.YU. Bogachev, O.V. Dzhenina, K.V. Komov

    Introduction. Varicose veins of lower extremities (VVLE) are among the most common forms of chronic venous disease (CVD) in pregnant women and are associated with a risk of thrombotic complications that impact maternal and fetal outcomes. Assessing the contribution of risk factors to the development of these complications during pregnancy and the early postpartum period allows for the prevention of these conditions and the reduction of patient risks. Aim of the research. To identify clinically significant risk factors for the development of thrombotic complications of VVLE in pregnant women to optimize preventive and therapeutic measures. Materials and methods. A prospective cohort study of 99 pregnant women with clinical manifestations of CVD class C2 according to the CEAP classification was performed. All patients received therapy with low molecular weight heparins (LMWH) in prophylactic or intermediate doses, depending on body weight. The following clinical risk factors were assessed: age >35 years, body mass index (BMI) ≥30 kg/m2, total score according to the RCOG scale ≥3 (risk scale of venous thromboembolic complications in pregnancy), VVLE onset before pregnancy, aggravated family history of VVLE/VTEC, use of assisted reproductive technologies (ART); adverse outcomes included superficial vein thrombophlebitis (SVT), deep vein thrombosis (DVT), and venous thromboembolic complications (VTEC). Inclusion criteria: confirmed pregnancy at study inclusion; presence of VVLE signs; age over 18 years. Exclusion criteria: extragenital pathology capable of independently influencing the risk of VVLE complications; VVLE complications prior to inclusion in the study. Comparison of indicators is performed using the χ² test. The assessment of the significance of the factor is determined by the odds ratio (OR) with a 95% confidence interval (95% CI). Results. Thrombotic complications were identified in 12 patients, all adverse events being lower limb SVT. BMI ≥30 kg/m2 was associated with a 7-fold increased risk of complications (38% vs 8%; p = 0.008; OR = 7.05; 95% CI 1.81-27.44), and a total RCOG score ≥3 was associated with a 12-fold increased risk (40% vs 3%; p = 0.001; OR = 12.4; 95% CI 2.53-60.66). Age >35 years, VVLE onset before pregnancy, family history of VVLE, and ART use did not significantly affect the incidence of complications. Conclusion. The incidence of VVLE complications in pregnant women in the study cohort was 12.1%, with the vast majority of episodes (91.7%) developing in the third trimester and postpartum period. A BMI ≥30 kg/m² and a total RCOG score ≥3 are significant risk factors for VVLE thrombotic complications, increasing the likelihood of their occurrence by approximately 7-fold and 12-fold, respectively. In contrast, age over 35 years, VVLE onset before pregnancy, a family history of VVLE, and the use of ART did not demonstrate a statistically significant impact on the risk of complications in this study. Combining the RCOG score with BMI analysis allows us to identify high-risk groups of pregnant women with VVLE and justify differentiated thromboprophylaxis and enhanced surveillance, particularly in the third trimester and early postpartum period. Preventive measures carried out in accordance with clinical recommendations (elastic compression, administration of prophylactic or intermediate doses of parenteral anticoagulants) are highly effective in preventing the occurrence of deep vein thrombosis and pulmonary embolism, but have shown questionable effectiveness in preventing the occurrence of thrombophlebitis of subcutaneous veins.

  • Open Access

    Surgical treatment of varicose veins of the lower extremities and the current comorbid background

    by B. V. Boldin, V. Yu. Bogachev, R. Abdoch, G. A. Varich, K. V. Komov, A. A. Slesareva, Р. Абдош

    Introduction. Varicose veins of the lower extremities are a common pathology affecting about 25–33% of the adult population. The treatment of this disease requires studying the influence of comorbidities on the choice of surgical treatment tactics for varicose veins.Aim. To assess the degree of influence of comorbid conditions on decision-making regarding the method of surgical intervention and to develop an algorithm for a personalized treatment approach.Materials and methods. A retrospective analysis of 500 medical records of patients who underwent surgical treatment for varicose veins was conducted using multivariate statistical analysis and machine learning methods to identify significant correlations. To assess long-term results, a prospective observation of 100 patients was additionally conducted for one year after surgery.Results. The results of the study showed that the presence of cardiovascular diseases increases the risk of postoperative complications by 23%, which requires correction of surgical tactics. A significant association between diabetes mellitus and increased duration of postoperative wound healing was revealed (p < 0.01). The analysis of long-term results showed that patients with comorbidities have a higher risk of varicose vein recurrence, especially in the presence of obesity and diabetes mellitus.Discussion. The results demonstrate the necessity of differentiated approach to the choice of surgical tactics taking into account the individual profile of the patient’s comorbidity.Conclusions. The developed prognostic algorithm and the proposed recommendations can serve as a basis for the creation of clinical guidelines aimed at improving the efficacy and safety of surgical treatment of varicose veins in patients with comorbidities.

  • Open Access

    Efficacy and safety of cava filters in patients with an extremely high risk of venous thromboembolic complications

    by A. V. Bocharov, K. A. Savostyanov, V. P. Mikhailenko, I. M. Dizengof, M. A. Kufa, A. Yu. Zarov, B. V. Boldin, G. A. Varich

    Introduction. In clinical practice, there are special situations when adequate anticoagulant therapy cannot be prescribed or does not prevent recurrence of PE. In such cases, the implantation of a cava filter seems to be the optimal treatment strategy, but the clinical efficacy and range of possible side effects of these devices remain unclear.Aim. To evaluate the effectiveness and safety of implantation of cava filters into the inferior vena cava for the prevention of PE.Materials and methods. The study included 530 patients with deep vein thrombosis of the lower extremities and an extremely high risk of PE in the period from 2008 to 2024. The CVF group consisted of 278 patients who had a cava filter implanted in the inferior vena cava, and the non-CVF group consisted of 252 patients who refused CVF implantation but had indications for its implantation. The primary endpoints of the study were death from any cause, confirmed PE with clinical manifestations, large or moderate bleeding, and the development of inferior vena cava syndrome. The secondary point in the CVF group was an embolism in the cava filter according to ultrasound examination.Results. There were no significant differences between the groups in terms of clinical and demographic indicators, primary endpoints. The frequency of detection of thrombotic masses in the cava filter at the hospital stage was 23 cases (8.27%).Discussion. When analyzing the Recommendations, CVF implantation in NSAIDs is recommended to be considered in special cases, however, according to the instructions of the ACCP, AHA and BSH, there are no indications for CVF implantation in all patients with DVT and/or PE who may be prescribed anticoagulant therapy.Conclusion. Any implantation of a cava filter, as a potentially unsafe device, should be carried out only after the decision of a multidisciplinary consultation.


  • Open Access

    Fixed-dose ruscus extract combination and its place in current clinical guidelines for the treatment of chronic venous diseases

    by V. Yu. Bogachev, B. V. Boldin, K. V. Komov, R. Abdoch, D. K. Kopnenkova, O. V. Dzhenina, Р. Абдош

    Chronic venous diseases (CVD) is the most common lower extremity vascular pathology. Various vein-specific symptoms and syndromes associated with CVD negatively affect all components of the quality of life in the modern society. The appearance and development of vein-specific symptoms have been proven to be associated with C-nociceptor irritation evoked by the so-called algogens – biologically active substances occurred due to vascular inflammation and endothelial dysfunction along with local temperature elevation and intravenous pressure. Endothelial dysfunction in CVD is mainly due to phlebostasis with a decrease in shear stress, leading to hypoxia of endothelial cells. Further, a multi-stage mechanism of leukocyte-endothelial interaction is activated, which results in the development of venous microangiopathy at the microcirculatory level, as well as the valve apparatus injury and varicose transformation of the principal superficial veins at the macrocirculatory level. It is evident that suppression of the leukocyte-endothelial inflammatory reaction not only leads to a reduction or relief of vein-specific symptoms, but also prevents macro- and microcirculatory disorders. In this regard, the so-called phlebotropic, or venoactive, pharmacological drugs targeting different pathogenetic mechanisms of development and progression of CVD present great interest. In this case, despite the common to this group of drugs phleboprotective effect, the specific mechanisms for achieving it may have significant differences in various venoactive agents. In this review, we discuss the main indications and instructions for the use of phlebotropic drugs in patients with CVD, drawing on the most established international and Russian clinical guidelines.


  • Open Access

    Photodynamic therapy in the complex treatment of trophic ulcers of venous etiology

    by B. V. Boldin, V. Yu. Bogachev, N. O. Somov, G. A. Varich, P. Yu. Golosnitskiy, K. V. Komov, П. Ю. Голосницкий

    Introduction. In Russia, more than 5 million people suffer from venous ulcers. According to general studies, in more than 10% of cases, venous ulcers lead to permanent disability in patients. Currently, there is a growing interest in the use of photodynamic therapy (PDT), which has already proven its effectiveness in various fields of medicine.Aim. To improve treatment outcomes in patients with venous trophic ulcers by incorporating photodynamic therapy into complex treatment.Materials and methods. A prospective comparative study was conducted in 213 patients with CEAP C6. In the main group (n = 100), treatment was carried out using photodynamic therapy. The control group (n = 113) received standard treatment for venous ulcers.Results. The bacteriological study revealed significant statistical differences in the reduction in the level of bacterial contamination in patients of the main group compared to the control group. A comparison of the standard treatment of venous ulcers and the treatment method using PDT for the entire period of treatment showed that the use of PDT in the complex treatment of venous ulcers reduces the time for clearing ulcers by 1.75 times, accelerates the appearance of granulation tissue by 1.66 times, and accelerates healing by 1.87 times (p < 0.05).Discussion. The introduction of new medical technologies into clinical practice helps to improve the results of treatment of venous ulcers. The use of PDT in the treatment of venous ulcers has demonstrated high clinical effectiveness.Conclusion. The results of the study convincingly show that photodynamic therapy accelerates reparative processes in the ulcer, improves the state of the microbial background, and, accordingly, accelerates the rate of epithelization of the trophic ulcer.

  • Open Access

    Fixed-dose combinations in pharmacotherapy of chronic venous diseases

    by V. Yu. Bogachev, B. V. Boldin, K. V. Komov, O. V. Dzhenina

    Chronic venous diseases are the most common vascular diseases of the lower extremities, negatively affecting all components of the quality of life in the modern society. Due to their high prevalence, the prevention and treatment of chronic venous diseases are one of the priorities of national healthcare systems in industrially developed countries. In recent years, numerous experimental and clinical studies have uncovered an important role of vascular inflammation and endothelial dysfunction in the pathogenesis of chronic venous diseases, which determine not only a wide range of vein-specific symptoms, but are also the main drivers of pathological remodelling of the vein wall and its valve apparatus, followed by the development of varicose syndrome and more severe chronic venous insufficiency. Modern knowledge of the pathogenesis of chronic venous diseases enables us to identify several priority strategies aimed at managing the basic pathophysiological mechanisms of the development and progression of the disease. Pharmacotherapy with phlebotropic drugs is one of them. Some of these drugs are able to inhibit the vein-specific inflammation, improve the microcirculatory bed regulation, increase the vein tone and contractility and, as a result, have a positive effect on the clinical signs of chronic venous disease. This review presents the mechanism of action of a phlebotropic drug that is new to the Russian Federation. It is a combination of Ruscus aculeatus extract (Ruscus extract) with hesperidin methyl chalcone (HMC) and ascorbic acid. Studies showed a high level of evidence of clinical efficacy and safety of this drug for the treatment of patients with various forms of chronic venous diseases. Due to the unique features of its mechanisms of action, the optimal focus groups for its use may include patients of different age groups with early-stage disease, in which vein-specific symptoms predominate, and patients with chronic venous oedema.